Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel L Roper

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Plos One|February 24, 2018
Development of improved therapeutic mesothelin-based vaccines for pancreatic cancerMichael White, Andrew Freistaedter, Gwendolyn J B Jones, et al.
The Journal of General Virology|May 30, 2015
Genome sequence and comparative virulence of raccoonpox virus: the first North American poxvirus sequenceClare Fleischauer, Chris Upton, Joseph Victoria, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 3, 2016
Murine mesothelin: characterization, expression, and inhibition of tumor growth in a murine model of pancreatic cancerEmmanuel Zervos, Steven Agle, Andrew G Freistaedter, et al.
Journal of Medical Virology|November 21, 2020
Mosquito-infecting virus Espirito Santo virus inhibits replication and spread of dengue virusAvian V White, Ming Fan, Jordan M Mazzara, et al.
Virology|December 4, 2009
Vaccinia virus A35R inhibits MHC class II antigen presentationKristina E Rehm, Ramsey F Connor, Gwendolyn J B Jones, et al.
Journal of Virology|October 16, 2009
The poxvirus A35 protein is an immunoregulatorKristina E Rehm, Gwendolyn J B Jones, Alice A Tripp, et al.
Immunology|January 14, 2010
Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class IIKristina E Rehm, Ramsey F Connor, Gwendolyn J B Jones, et al.
Annual Review of Medicine|January 22, 2005
Severe acute respiratory syndrome (SARS): a year in reviewDanuta M Skowronski, Caroline Astell, Robert C Brunham, et al.
Vaccines|September 23, 2022
Waning of SARS-CoV-2 Seropositivity among Healthy Young Adults over Seven MonthsC Suzanne Lea, Kristina Simeonsson, Aaron M Kipp, et al.
Frontiers in Pharmacology|July 24, 2025
The GPR4 antagonist NE-52-QQ57 increases survival, mitigates the hyperinflammatory response and reduces viral load in SARS-CoV-2-infected K18-hACE2 transgenic miceXin-Jun Wu, Karen A Oppelt, Ming Fan, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Plos One|February 24, 2018
Development of improved therapeutic mesothelin-based vaccines for pancreatic cancerMichael White, Andrew Freistaedter, Gwendolyn J B Jones, et al.
The Journal of General Virology|May 30, 2015
Genome sequence and comparative virulence of raccoonpox virus: the first North American poxvirus sequenceClare Fleischauer, Chris Upton, Joseph Victoria, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 3, 2016
Murine mesothelin: characterization, expression, and inhibition of tumor growth in a murine model of pancreatic cancerEmmanuel Zervos, Steven Agle, Andrew G Freistaedter, et al.
Journal of Medical Virology|November 21, 2020
Mosquito-infecting virus Espirito Santo virus inhibits replication and spread of dengue virusAvian V White, Ming Fan, Jordan M Mazzara, et al.
Virology|December 4, 2009
Vaccinia virus A35R inhibits MHC class II antigen presentationKristina E Rehm, Ramsey F Connor, Gwendolyn J B Jones, et al.
Journal of Virology|October 16, 2009
The poxvirus A35 protein is an immunoregulatorKristina E Rehm, Gwendolyn J B Jones, Alice A Tripp, et al.
Immunology|January 14, 2010
Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class IIKristina E Rehm, Ramsey F Connor, Gwendolyn J B Jones, et al.
Annual Review of Medicine|January 22, 2005
Severe acute respiratory syndrome (SARS): a year in reviewDanuta M Skowronski, Caroline Astell, Robert C Brunham, et al.
Vaccines|September 23, 2022
Waning of SARS-CoV-2 Seropositivity among Healthy Young Adults over Seven MonthsC Suzanne Lea, Kristina Simeonsson, Aaron M Kipp, et al.
Frontiers in Pharmacology|July 24, 2025
The GPR4 antagonist NE-52-QQ57 increases survival, mitigates the hyperinflammatory response and reduces viral load in SARS-CoV-2-infected K18-hACE2 transgenic miceXin-Jun Wu, Karen A Oppelt, Ming Fan, et al.
Pageof 4